Whitaker, Chief Legal Officer of 10x Genomics. "We are pleased with this resolution on ATAC as we continue to defend the asserted Brenner patents on appeal." The company's litigation against Parse ...
Hosted on MSN7mon
10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates10x Genomics, which belongs to the Zacks Medical Info Systems industry, posted revenues of $153.1 million for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 1.46%. This ...
Coupled with the invalidation of 10x Genomics’ 10,155,981 patent last year, Parse has now invalidated all claims that 10x Genomics asserts against Parse products, further reinforcing Parse’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback